Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Bank Oke Indonesia Tbk (DNAR) vs UBC Medical Indonesia Tbk. (LABS)

Bank Oke Indonesia TbkTrading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Bank Oke Indonesia Tbk dan UBC Medical Indonesia Tbk.: Bank Oke Indonesia Tbk diperdagangkan di Rp112 (kapitalisasi pasar 1,86 T, volume 24 jam 1,74 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Bank Oke Indonesia Tbk jauh lebih besar — sekitar 3,2× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Bank Oke Indonesia Tbk lebih aktif diperdagangkan (1,74 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.

DNARLABS
Kapitalisasi Pasar
1,86 T584,6 M
Volume
1,74 jt817,3 rb
Lot
17,35 rb8,17 rb
Perputaran
193,18 jt120,01 jt
Harga Rata-rata
111,34146,84
Nilai Transaksi
193,18 jt120,01 jt
Harga Ekuilibrium Indikatif
112146
Volume Ekuilibrium Indikatif
95059

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

DNAR
Lihat detail
LABS
Lihat detail

Tentang Bank Oke Indonesia Tbk

PT Bank Dinar Indonesia Tbk (the Bank) formerly PT Bank Liman International was established based on Notarial Deed No. 99 dated August 15, 1990 of James Herman Rahardjo, S.H.

Selengkapnya di halaman DNAR

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS